文章基本信息

标题：The cost and value of cancer drugs – are new innovations outpacing our ability to pay?
本地全文：下载
作者：Daniel A. Goldstein ; Salomon M. Stemmer ; Noa Gordon 等
期刊名称：Israel Journal of Health Policy Research
印刷版ISSN：2045-4015
电子版ISSN：2045-4015
出版年度：2016
卷号：5
期号：1
页码：40
DOI：10.1186/s13584-016-0097-0
语种：English
出版社：BioMed Central
摘要：Cancer drug expenditures have been increasing significantly in countries around the world. A recent paper in the IJHPR provides new knowledge and insights into this global phenomenon by analyzing how it is playing out in an Israeli health plan with over two million members, whose state-of-the-art information systems provide an opportunity to explore these changes in a comprehensive, detailed and reliable manner. There is a wide variation in both the cost-effectiveness and the budget impact of individual drugs. These issues also vary when analyzing drugs in other countries due to differential pricing mechanisms. In addition to drug expenditure, the overall cost of cancer care is increasing, partly due to expenditures on non-pharmacologic treatments and diagnostic testing. With the arrival of new therapies, the future of cancer care is exciting. However, there will be many challenges ahead with regard to the ability to pay for such innovations. In this commentary we discuss the current problems and anticipate the future challenges.
关键词：Cancer Care ; Generic Drug ; Cancer Drug ; Drug Price ; Pertuzumab